Novartis (NVS) Reports In-Line Q3 EPS of $1.21; Guides FY15 Sales Growth
Go back to Novartis (NVS) Reports In-Line Q3 EPS of $1.21; Guides FY15 Sales Growth| NOVARTIS AG (NYSE: NVS) | Delayed: 148.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.93 | 52 Week High | $89.15 | |||
| Open | $148.93 | 52 Week Low | $69.84 | |||
| Day High | $148.93 | P/E | N/A | |||
| Day Low | $148.93 | EPS | $0.00 | |||
| Volume | 1,089 | |||||
